Pharmacokinetics were characterised in MabCampath-naive patients with B-cell chronic lymphocytic leukaemia (B-CLL) who had failed previous therapy with purine analogues.
Farmakokineetikat kirjeldati B- rakulise kroonilise lümfoleukeemiaga (B- KLL) MabCampath´i patsientidel, kellel eelnev ravi puriini analoogidega ei andnud tulemust.